What is the share price of SMS Lifesciences India Ltd (SMSLIFE) today?
The share price of SMSLIFE as on 11th July 2025 is ₹1157.10. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on SMS Lifesciences India Ltd (SMSLIFE) share?
The past returns of SMS Lifesciences India Ltd (SMSLIFE) share are- Past 1 week: -2.23%
- Past 1 month: -2.15%
- Past 3 months: 3.54%
- Past 6 months: -6.44%
- Past 1 year: 32.99%
- Past 3 years: 66.96%
- Past 5 years: 220.30%
What are the peers or stocks similar to SMS Lifesciences India Ltd (SMSLIFE)?
The peers or stocks similar to SMS Lifesciences India Ltd (SMSLIFE) include:What is the dividend yield % of SMS Lifesciences India Ltd (SMSLIFE) share?
The current dividend yield of SMS Lifesciences India Ltd (SMSLIFE) is 0.13.What is the market cap of SMS Lifesciences India Ltd (SMSLIFE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of SMS Lifesciences India Ltd (SMSLIFE) is ₹349.82 Cr as of 11th July 2025.What is the 52 week high and low of SMS Lifesciences India Ltd (SMSLIFE) share?
The 52-week high of SMS Lifesciences India Ltd (SMSLIFE) is ₹1749.65 and the 52-week low is ₹815.What is the PE and PB ratio of SMS Lifesciences India Ltd (SMSLIFE) stock?
The P/E (price-to-earnings) ratio of SMS Lifesciences India Ltd (SMSLIFE) is 17.40. The P/B (price-to-book) ratio is 1.81.Which sector does SMS Lifesciences India Ltd (SMSLIFE) belong to?
SMS Lifesciences India Ltd (SMSLIFE) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy SMS Lifesciences India Ltd (SMSLIFE) shares?
You can directly buy SMS Lifesciences India Ltd (SMSLIFE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
SMS Lifesciences India Ltd
SMSLIFE Share Price
1,157.102.18% (-25.80)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
SMSLIFE Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
SMSLIFE Performance & Key Metrics
SMSLIFE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 17.40 | 1.81 | 0.13% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.68 | 6.41 | 0.79% |
SMSLIFE Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
SMSLIFE Company Profile
SMS Lifesciences India is engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of organic and inorganic chemicals,pharmaceuticals
SUNPHARMA
PE Ratio
36.71
36.71
1Y Return
5.71%
5.71%
Buy Reco %
87.10
87.10
CIPLA
PE Ratio
22.75
22.75
1Y Return
1.39%
1.39%
Buy Reco %
73.33
73.33
TORNTPHARM
PE Ratio
58.69
58.69
1Y Return
12.03%
12.03%
Buy Reco %
70.83
70.83
MANKIND
PE Ratio
53.44
53.44
1Y Return
21.78%
21.78%
Buy Reco %
81.25
81.25
DRREDDY
PE Ratio
18.46
18.46
1Y Return
4.87%
4.87%
Buy Reco %
50.00
50.00
SMSLIFE Forecast
SMSLIFE Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
SMSLIFE
SMSLIFE
Income
Balance Sheet
Cash Flow
Annual Normal View
SMSLIFE Income Statement
SMSLIFE Income Statement
Annual Normal View
| Financial Year | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 380.36 | 263.06 | 267.37 | 364.50 | 320.98 | 309.79 | 349.58 | 349.60 | ||||||||
Raw Materials | 268.79 | 147.04 | 135.17 | 204.47 | 171.33 | 150.19 | 299.68 | 299.70 | ||||||||
| Power & Fuel Cost | 25.93 | 20.48 | 21.56 | 30.02 | 29.28 | 30.46 | ||||||||||
| Employee Cost | 23.11 | 26.56 | 30.66 | 39.90 | 43.43 | 49.27 | ||||||||||
| Selling & Administrative Expenses | 11.98 | 9.28 | 12.28 | 13.77 | 12.52 | 14.20 | ||||||||||
| Operating & Other expenses | 13.28 | 32.02 | 35.68 | 27.37 | 30.18 | 30.62 | ||||||||||
EBITDA | 37.27 | 27.68 | 32.02 | 48.97 | 34.24 | 35.05 | 49.90 | 49.90 | ||||||||
| Depreciation/Amortization | 6.38 | 7.86 | 7.86 | 10.01 | 10.79 | 14.94 | 15.00 | 15.00 | ||||||||
| PBIT | 30.89 | 19.82 | 24.16 | 38.96 | 23.45 | 20.11 | 34.90 | 34.90 | ||||||||
| Interest & Other Items | 5.51 | 5.15 | 4.60 | 6.23 | 6.87 | 10.26 | 8.71 | 8.71 | ||||||||
| PBT | 25.38 | 14.67 | 19.56 | 32.73 | 16.58 | 9.85 | 26.19 | 26.19 | ||||||||
| Taxes & Other Items | 7.54 | 4.49 | 6.02 | 7.41 | 5.13 | 0.75 | 6.08 | 6.08 | ||||||||
| Net Income | 17.84 | 10.18 | 13.54 | 25.32 | 11.45 | 9.10 | 20.11 | 20.11 | ||||||||
| EPS | 59.01 | 33.67 | 44.79 | 83.75 | 37.87 | 30.10 | 66.51 | 66.52 | ||||||||
| DPS | 1.50 | 0.00 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | ||||||||
| Payout ratio | 0.03 | 0.00 | 0.03 | 0.02 | 0.04 | 0.05 | 0.02 | 0.02 |
SMSLIFE Company Updates
SMSLIFE Stock Peers
SMSLIFE Past Performance & Peer Comparison
SMSLIFE Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| SMS Lifesciences India Ltd | 17.40 | 1.81 | 0.13% |
| Sun Pharmaceutical Industries Ltd | 36.71 | 5.53 | 0.96% |
| Cipla Ltd | 22.75 | 3.83 | 1.08% |
| Torrent Pharmaceuticals Ltd | 58.69 | 14.78 | 0.18% |
SMSLIFE Stock Price Comparison
Compare SMSLIFE with any stock or ETFCompare SMSLIFE with any stock or ETF
SMSLIFE
SMSLIFE Holdings
SMSLIFE Shareholdings
SMSLIFE Promoter Holdings Trend
SMSLIFE Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
SMSLIFE Institutional Holdings Trend
SMSLIFE Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
SMSLIFE Shareholding Pattern
SMSLIFE Shareholding Pattern
SMSLIFE Shareholding History
SMSLIFE Shareholding History
Foreign Institutions
smallcases containing SMSLIFE stock
smallcases containing SMSLIFE stock
Looks like this stock is not in any smallcase yet.
SMSLIFE Events
SMSLIFE Events
SMSLIFE Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SMSLIFE has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.13%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.30 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
SMSLIFE Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SMSLIFE has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.13%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.30 every year
SMSLIFE Upcoming Dividends
SMSLIFE Upcoming Dividends
No upcoming dividends are available
SMSLIFE Past Dividends
SMSLIFE Past Dividends
Cash Dividend
Ex DateEx DateSep 23, 2024
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Sep 23, 2024
Cash Dividend
Ex DateEx DateSep 22, 2023
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Sep 22, 2023
Cash Dividend
Ex DateEx DateSep 22, 2022
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Sep 22, 2022
Cash Dividend
Ex DateEx DateSep 20, 2021
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Sep 20, 2021
Cash Dividend
Ex DateEx DateSep 19, 2019
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Sep 19, 2019
SMSLIFE Stock News & Opinions
SMSLIFE Stock News & Opinions
Articles & Videos
Earnings
SMS Lifesciences India consolidated net profit declines 49.66% in the March 2025 quarter
Net profit of SMS Lifesciences India declined 49.66% to Rs 2.97 crore in the quarter ended March 2025 as against Rs 5.90 crore during the previous quarter ended March 2024. Sales declined 0.98% to Rs 89.11 crore in the quarter ended March 2025 as against Rs 89.99 crore during the previous quarter ended March 2024. For the full year,net profit rose 121.23% to Rs 20.11 crore in the year ended March 2025 as against Rs 9.09 crore during the previous year ended March 2024. Sales rose 12.67% to Rs 344.72 crore in the year ended March 2025 as against Rs 305.96 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales89.1189.99 -1 344.72305.96 13 OPM %8.3312.62 -13.0710.17 - PBDT7.7310.88 -29 41.1924.78 66 PBT3.937.10 -45 26.199.85 166 NP2.975.90 -50 20.119.09 121 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Board of SMS LifeSciences India recommends final dividend
SMS LifeSciences India announced that the Board of Directors of the Company at its meeting held on 29 May 2025, inter alia, have recommended the final dividend of Rs 1.5 per equity Share (i.e. 15%) , subject to the approval of the shareholders.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
SMS LifeSciences India to announce Quarterly Result
SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
SMS Lifesciences India spurts as Q3 PAT jumps 18% YoY to Rs 5 cr
Revenue from operations was at Rs 84.60 crore in the third quarter of FY25, marking a growth of 17.41% compared with Rs 72.05 crore in Q3 FY24. In Q3 FY25, the profit before tax (PBT) spiked 81.36% year on year (YoY) to Rs 6.91 crore. Total expenses added 12.96% YoY to Rs 77.74 crore in the quarter ended 31 December 2024. Cost of materials consumed was at Rs 39.43 crore (up 0.61% YoY), and employee benefits expense was at Rs 14.60 crore (up 9.69% YoY) during the period under review. On a nine-month basis, the company reported consolidated net profit of Rs 15.24 crore in 9M FY25, compared with net loss of Rs 0.14 crore posted in 9M FY24. Revenue from operations jumped 18.35% YoY to Rs 255.61 crore in 9M FY25. Meanwhile, the board has approved the reappointment of Veeravenkata Satyanarayana Murthy Talluri as managing director (MD) of the company for a further period of 3 consecutive year's w.e.f. 1 June 2025. SMS Lifesciences India is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents, and generally dealing with all types of organic & inorganic chemicals, pharmaceuticals, active pharmaceutical ingredients (API), and intermediates. Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
SMS Lifesciences India consolidated net profit rises 27.21% in the December 2024 quarter
Net profit of SMS Lifesciences India rose 27.21% to Rs 5.47 crore in the quarter ended December 2024 as against Rs 4.30 crore during the previous quarter ended December 2023. Sales rose 17.42% to Rs 84.60 crore in the quarter ended December 2024 as against Rs 72.05 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales84.6072.05 17 OPM %15.0712.89 - PBDT10.677.54 42 PBT6.923.81 82 NP5.474.30 27 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
SMS LifeSciences India to announce Quarterly Result
SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
SMS Lifesciences India consolidated net profit rises 586.76% in the September 2024 quarter
Net profit of SMS Lifesciences India rose 586.76% to Rs 4.67 crore in the quarter ended September 2024 as against Rs 0.68 crore during the previous quarter ended September 2023. Sales rose 13.28% to Rs 78.46 crore in the quarter ended September 2024 as against Rs 69.26 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales78.4669.26 13 OPM %10.9111.45 - PBDT8.475.39 57 PBT4.701.66 183 NP4.670.68 587 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
SMS LifeSciences India to conduct board meeting
SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
SMS LifeSciences India AGM scheduled
SMS LifeSciences India announced that the 18th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Earnings
SMS Lifesciences India reports consolidated net profit of Rs 7.00 crore in the June 2024 quarter
Net profit of SMS Lifesciences India reported to Rs 7.00 crore in the quarter ended June 2024 as against net loss of Rs 1.80 crore during the previous quarter ended June 2023. Sales rose 23.98% to Rs 92.55 crore in the quarter ended June 2024 as against Rs 74.65 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales92.5574.65 24 OPM %17.593.39 - PBDT14.320.97 1376 PBT10.64-2.73 LP NP7.00-1.80 LP Powered by Capital Market - Live
11 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 5.85%, vs industry avg of 10.1%
Over the last 5 years, market share decreased from 0.1% to 0.08%
Over the last 5 years, net income has grown at a yearly rate of 14.59%, vs industry avg of 20.04%